出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年4月
デジタル PCR (dPCR) およびリアルタイム PCR (qPCR) 市場 : 製品 (機器、試薬と消耗品、ソフトウェアとサービス)、用途 (臨床、研究、法医学)、エンド ユーザー (病院、診断ラボ、製薬、バイオテクノロジー、CRO) – 2028年までの世界予測
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) – Global Forecast to 2028
| ページ数 | 470 |
| 図表数 | 549 |
| 種別 | 英文調査報告書 |
| 価格 |
The global Digital PCR and Real-time PCR Market is consolidated market. The market is estimated to grow to USD 12.4 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 7.8%. The growth of this market is due to factors such as the rising infectious diseases and genetic disorders, continuous advancements in PCR technologies, and increasing investments. However, high instrument costs—especially that of dPCR—and the technical limitations of PCR are restraining market growth.
“By product & service, the consumables & reagent segment is expected to grow at the highest during the forecast period.”
On the basis of product & service, the dPCR and qPCR market is segmented into reagents and consumables; instruments; and software and services. This segment includes specific reagents (such as master mixes, assay kits, and enzymes) and consumables (such as reaction tubes, needles, and vials) used during dPCR procedures. Generally, dPCR reagents consist of a super mix or a master mix that contains the buffer, DNA polymerase, dNTPs, and dsDNA-binding dyes. The reagents and consumables segment is expected to witness the highest growth during the forecast period. The dPCR and qPCR products are increasingly used by researchers and healthcare professionals due to the ongoing automation and miniaturization of qPCR/dPCR instruments, the commercialization of advanced software, and the availability of customized laboratory reagents such factors are expected to drive the growth of the qPCR and dPCR reagents and consumables market.
“By application, the clinical applications segment is expected to grow at the highest CAGR during the forecast period.”
The clinical applications segment is estimated to dominate the qPCR and dPCR applications market during the forecast period. The key factors driving the market growth include the growing usage of qPCR in disease diagnosis, growing public emphasis on early & effective disease diagnosis & treatment, technological benefits offered by dPCR such as high flexibility, increased device sensitivity, better precision, and absolute quantification of target molecule, and the increasing global burden of cancer are key factors that will drive the market for clinical applications during the forecast period.
“By end-user, the hospitals and diagnostics centers segment dominated the market during the forecast period.”
The hospital and diagnostic laboratories dominated the Digital PCR and Real-time PCR Market during the forecast period. This can be attributed to the increasing market availability of qPCR reagents for clinical diagnostic applications, the ongoing expansion of healthcare infrastructure across emerging countries, the high prevalence of target diseases, and growing awareness among end users related to the benefits offered by qPCR for clinical diagnosis, the growing demand for early and efficient disease diagnosis and treatment, and the increasing number of dPCR product launches for diagnostic applications.
“Asia Pacific dPCR and qPCR market is expected to witness the highest growth during the forecast period.”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period primarily due to the ongoing expansion and modernization of the healthcare infrastructure in emerging Asian countries, increasing number of research projects in China, India, and Japan in the field of genomics and oncology, rising trend of clinical research being outsourced to Asia-based CROs by leading drug manufacturing companies, and continuous government support for genomics-based research activities in emerging Asia Pacific countries.
A breakdown of the primary participants referred to for this report is provided below:
• By Respondent: Supply Side – 70%, Demand Side – 30%
• By Designation: Managers–45%, CXOs and Directors – 30%, and Executives – 25%
• By Region: North America–40%, Europe–25%, Asia Pacific–20%, RoW-15%
Prominent players in the global digital PCR (dPCR) and real-time PCR (qPCR) market are, Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies, Inc. (US), Becton, Dickinson and Company (US), Takara Bio Inc. (Japan), Danaher Corporation (US), Eppendorf (Germany), Promega Corporation (US), Merck KGaA (Germany), QIAGEN (Germany), BioMérieux (France), Meridian Bioscience (US), Quidel Corporation (US), Enzo Biochem, Inc. (US), Stilla (France), Standard BioTools (US), ENDRESS+HAUSER Group Services AG (ENDRESS+HAUSER) (Switzerland), JN Medsys (Singapore), BIONEER CORPORATION (South Korea), ELITech Group (France), QuantaBio (US), Sacace Biotechnologies Srl (Italy), Bio Molecular Systems (Australia), Biomeme, Inc. (US), Kyratec (Australia), LGC Bioresearch Technologies (England), Antylia Scientific (US), and Genome Diagnostics Pvt. Ltd. (India).
Research Coverage:
The report analyzes the dPCR and qPCR market and aims at estimating the market size and future growth potential. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a more significant share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their market presence.
The report provides insights on the following pointers:
• Analysis of key drivers (Rising incidence and prevalence of target infectious diseases and genetic disorders, continuous advancements in PCR technologies, growing importance of PCR in biomarker discovery), restraints (High device costs associated with dPCR, technical limitations of qPCR and dPCR ), opportunities (Growing market penetration in emerging countries), and challenges (Time-consuming methodology involving sample handling and post-PCR analysis, Lack of accuracy and standardization in protocols) influencing the growth of the Digital PCR and Real-time PCR Market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Digital PCR and Real-time PCR Market
• Market Development: Comprehensive information about lucrative markets – the report analyses the Digital PCR and Real-time PCR Market across varied regions
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Digital PCR and Real-time PCR market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies, Inc. (US), Becton, Dickinson and Company (US), Takara Bio Inc. (Japan), and Danaher Corporation (US).
目次
1 INTRODUCTION 53
1.1 STUDY OBJECTIVES 53
1.2 MARKET DEFINITION 53
1.2.1 INCLUSIONS & EXCLUSIONS 54
1.3 STUDY SCOPE 54
1.3.1 MARKETS COVERED 54
1.3.2 YEARS CONSIDERED 55
1.4 CURRENCY 55
1.5 LIMITATIONS 55
1.6 STAKEHOLDERS 56
1.7 SUMMARY OF CHANGES 56
1.7.1 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH APPROACH 57
FIGURE 1 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: RESEARCH DESIGN 57
2.1.1 SECONDARY RESEARCH 58
2.1.2 PRIMARY RESEARCH 59
FIGURE 2 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: BREAKDOWN OF PRIMARIES 60
2.2 MARKET SIZE ESTIMATION 60
FIGURE 3 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2022) 60
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 – REVENUE SHARE ANALYSIS (2022) 61
FIGURE 5 ILLUSTRATIVE EXAMPLE OF QIAGEN: REVENUE SHARE ANALYSIS (2022) 62
2.2.1 KEY INDUSTRY INSIGHTS 63
2.3 GROWTH FORECAST 64
FIGURE 6 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: CAGR PROJECTIONS, 2023–2028 64
FIGURE 7 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 66
FIGURE 8 DATA TRIANGULATION METHODOLOGY 66
2.5 RESEARCH ASSUMPTIONS 67
2.6 RISK ANALYSIS 67
2.7 RECESSION IMPACT 67
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 67
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 68
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 68
3 EXECUTIVE SUMMARY 69
FIGURE 9 GLOBAL REAL-TIME PCR PRODUCTS & SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 70
FIGURE 10 GLOBAL DIGITAL PCR PRODUCTS & SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 71
FIGURE 11 GLOBAL REAL-TIME PCR MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 72
FIGURE 12 GLOBAL DIGITAL PCR MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 73
FIGURE 13 GLOBAL REAL-TIME PCR MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 74
FIGURE 14 GLOBAL DIGITAL PCR MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 75
FIGURE 15 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: GEOGRAPHICAL SNAPSHOT 76
4 PREMIUM INSIGHTS 77
4.1 GLOBAL DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET OVERVIEW 77
FIGURE 16 RISING INCIDENCE AND PREVALENCE OF TARGET INFECTIOUS DISEASES & GENETIC DISORDERS EXPECTED TO DRIVE MARKET GROWTH 77
4.2 ASIA PACIFIC: DPCR AND QPCR MARKET OVERVIEW (2022) 78
FIGURE 17 ONGOING EXPANSION AND MODERNIZATION OF HEALTHCARE INFRASTRUCTURE IN EMERGING ASIAN COUNTRIES TO DRIVE MARKET GROWTH 78
4.3 GEOGRAPHICAL SNAPSHOT OF DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET 79
FIGURE 18 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 79
5 MARKET OVERVIEW 80
5.1 INTRODUCTION 80
5.2 MARKET DYNAMICS 80
FIGURE 19 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 80
5.2.1 DRIVERS 81
5.2.1.1 Rising incidence and prevalence of target infectious diseases and genetic disorders 81
FIGURE 20 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2021 81
5.2.1.2 Continuous advancements in PCR technologies 82
FIGURE 21 TRADITIONAL PCR VS. QPCR AND DPCR 83
5.2.1.3 Growing importance of PCR in biomarker discovery 83
5.2.2 RESTRAINTS 84
5.2.2.1 High device costs associated with dPCR 84
5.2.2.2 Technical limitations of qPCR and dPCR 84
5.2.3 OPPORTUNITIES 85
5.2.3.1 Growing market penetration in emerging countries 85
5.2.4 CHALLENGES 85
5.2.4.1 Time-consuming methodology involving sample handling and post-PCR analysis 85
5.2.4.2 Lack of accuracy & standardization in protocols 86
5.3 PORTER’S FIVE FORCES ANALYSIS 87
5.3.1 OVERVIEW 87
TABLE 4 IMPACT OF PORTER’S FIVE FORCES ANALYSIS ON DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET 87
5.3.2 INTENSITY OF COMPETITIVE RIVALRY 87
5.3.3 BARGAINING POWER OF SUPPLIERS 87
5.3.4 BARGAINING POWER OF BUYERS 87
5.3.5 THREAT FROM NEW ENTRANTS 88
5.3.6 THREAT FROM SUBSTITUTES 88
5.4 GLOBAL REGULATORY LANDSCAPE 88
5.4.1 KEY REGULATORY AGENCIES 88
5.5 VALUE CHAIN ANALYSIS 89
FIGURE 22 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING REGULATION AND DISTRIBUTION STAGES 89
5.5.1 RESEARCH & DEVELOPMENT 89
5.5.2 EVALUATION AND ADAPTATION 90
5.5.3 REGULATIONS VIA NATIONAL AND INTERNATIONAL BODIES 90
5.5.4 POST-DELIVERY SUPPORT 90
5.6 SUPPLY CHAIN ANALYSIS 90
5.6.1 PROMINENT COMPANIES 90
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES 90
5.6.3 END USERS 90
FIGURE 23 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: SUPPLY CHAIN ANALYSIS 91
5.7 TECHNOLOGY ANALYSIS 91
5.7.1 DEVELOPMENT OF PORTABLE INSTRUMENTS USING PCR DIAGNOSTIC SERVICES 91
5.8 ECOSYSTEM ANALYSIS 92
TABLE 5 SUPPLY CHAIN ECOSYSTEM 92
5.9 PATENT ANALYSIS 94
5.10 PRICING ANALYSIS 95
TABLE 6 AVERAGE PRICE RANGE OF PCR PRODUCTS, BY KEY PLAYERS (USD) 95
5.11 TRADE ANALYSIS 96
TABLE 7 IMPORT DATA FOR PCR ANALYZERS (HS CODE 3822), BY COUNTRY, 2017–2021 (USD) 96
TABLE 8 EXPORT DATA FOR PCR ANALYZERS (HS CODE 3822), BY COUNTRY, 2017–2021 (USD) 96
5.12 KEY CONFERENCES AND EVENTS (2023) 97
TABLE 9 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET: LIST OF MAJOR CONFERENCES AND EVENTS 97
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 98
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY END USER 98
TABLE 10 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 98
5.13.2 BUYING CRITERIA 98
FIGURE 24 KEY BUYING CRITERIA, BY END USER 98
6 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET, BY PRODUCT & SERVICE 99
6.1 INTRODUCTION 100
TABLE 11 DPCR AND QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 100
6.2 QPCR 100
TABLE 12 QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 13 NORTH AMERICA: QPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 14 EUROPE: QPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 15 ASIA PACIFIC: QPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 16 LATIN AMERICA: QPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 17 QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 103
6.2.1 QPCR REAGENTS AND CONSUMABLES 104
6.2.1.1 Rise in probe-based multiplex genetic analysis procedures to drive qPCR reagents and consumables market 104
TABLE 18 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 19 NORTH AMERICA: QPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 20 EUROPE: QPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 21 ASIA PACIFIC: QPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 22 LATIN AMERICA: QPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.2.1.2 qPCR reagents and consumables market, by application 107
TABLE 23 QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 107
6.2.1.3 qPCR reagents and consumables market, by end user 107
TABLE 24 QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2021–2028 (USD MILLION) 107
6.2.2 QPCR INSTRUMENTS 108
6.2.2.1 Growing adoption of qPCR instruments to drive market 108
TABLE 25 QPCR INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 26 NORTH AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 27 EUROPE: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 28 ASIA PACIFIC: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 29 LATIN AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.2.2.2 qPCR instruments market, by application 110
TABLE 30 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
6.2.2.3 qPCR instruments market, by end user 111
TABLE 31 QPCR INSTRUMENTS MARKET, BY END USER, 2021–2028 (USD MILLION) 111
6.2.3 QPCR SOFTWARE AND SERVICES 111
6.2.3.1 Rising demand for specialized qPCR analysis software to boost market 111
TABLE 32 QPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 33 NORTH AMERICA: QPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 34 EUROPE: QPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 35 ASIA PACIFIC: QPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 36 LATIN AMERICA: QPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
6.2.3.2 qPCR software and services market, by application 114
TABLE 37 QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 114
6.2.3.3 qPCR software and services market, by end user 115
TABLE 38 QPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 115
6.3 DPCR 115
6.3.1 GROWING PRIVATE FUNDING FOR DEVELOPMENT AND COMMERCIALIZATION OF INNOVATIVE DPCR INSTRUMENTS TO DRIVE MARKET 115
TABLE 39 DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 116
TABLE 40 DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 41 NORTH AMERICA: DPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 42 EUROPE: DPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 43 ASIA PACIFIC: DPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 44 LATIN AMERICA: DPCR PRODUCTS & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.3.2 DPCR REAGENTS AND CONSUMABLES 119
6.3.2.1 Rising incidence of infectious disease and availability of novel dPCR reagents worldwide to drive market 119
TABLE 45 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 46 NORTH AMERICA: DPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 47 EUROPE: DPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 48 ASIA PACIFIC: DPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 49 LATIN AMERICA: DPCR REAGENTS AND CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
6.3.2.2 dPCR reagents and consumables market, by application 122
TABLE 50 DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 122
6.3.2.3 dPCR reagents and consumables market, by end user 122
TABLE 51 DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2021–2028 (USD MILLION) 122
6.3.3 DPCR INSTRUMENTS 123
6.3.3.1 Rise in dPCR-based genetic research activities worldwide to drive market growth 123
TABLE 52 DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 53 DPCR INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 54 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 55 EUROPE: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 56 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 57 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
6.3.3.2 dPCR instruments market, by application 126
TABLE 58 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
6.3.3.3 dPCR instruments market, by end user 127
TABLE 59 DPCR INSTRUMENTS MARKET, BY END USER, 2021–2028 (USD MILLION) 127
6.3.3.4 Droplet digital PCR 127
6.3.3.4.1 Advantages of ddPCR to boost adoption 127
TABLE 60 DROPLET DIGITAL PCR MARKET, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 61 NORTH AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 62 EUROPE: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 63 ASIA PACIFIC: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 64 LATIN AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 130
6.3.3.5 Chip-based digital PCR 130
6.3.3.5.1 Rise in genetic research activities to propel market growth 130
TABLE 65 CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 66 NORTH AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 67 EUROPE: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 68 ASIA PACIFIC: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 69 LATIN AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
6.3.3.6 BEAMing digital PCR 133
6.3.3.6.1 Growing application of BEAMing digital PCR in cancer research to favor market 133
TABLE 70 BEAMING DIGITAL PCR MARKET, BY REGION, 2021–2028 (USD MILLION) 133
TABLE 71 NORTH AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 72 EUROPE: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 73 ASIA PACIFIC: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 74 LATIN AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
6.3.4 DPCR SOFTWARE AND SERVICES 136
6.3.4.1 Easy-to-use interfaces and simplified workflows to support market growth 136
TABLE 75 DPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 76 NORTH AMERICA: DPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 77 EUROPE: DPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 78 ASIA PACIFIC: DPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 79 LATIN AMERICA: DPCR SOFTWARE AND SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
6.3.4.2 dPCR software and services market, by application 139
TABLE 80 DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
6.3.4.3 dPCR software and services market, by end user 139
TABLE 81 DPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 139
7 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET, BY APPLICATION 140
7.1 INTRODUCTION 141
TABLE 82 DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 141
7.2 QPCR APPLICATIONS 141
TABLE 83 QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
7.2.1 QPCR CLINICAL APPLICATIONS 142
TABLE 84 QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 85 QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 86 NORTH AMERICA: QPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 87 EUROPE: QPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 88 ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 89 LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
7.2.1.1 Infectious disease testing 146
7.2.1.1.1 Wide availability of qPCR assays and kits for infectious disease testing to drive market 146
TABLE 90 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 91 NORTH AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 92 EUROPE: QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 93 ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 94 LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 148
7.2.1.2 Oncology testing 149
7.2.1.2.1 Growing use of qPCR techniques in tumor profiling to aid growth 149
TABLE 95 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2021–2028 (USD MILLION) 149
TABLE 96 NORTH AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 97 EUROPE: QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 98 ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 99 LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 151
7.2.1.3 Blood screening 152
7.2.1.3.1 Elimination of post-amplification processing and easy process automation to boost growth 152
TABLE 100 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2021–2028 (USD MILLION) 152
TABLE 101 NORTH AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 102 EUROPE: QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 103 ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 104 LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 154
7.2.1.4 Transplant diagnostics 155
7.2.1.4.1 Increasing commercialization of qPCR products for transplant diagnostics to drive growth 155
TABLE 105 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION) 155
TABLE 106 NORTH AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 107 EUROPE: QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 108 ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 109 LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 157
7.2.1.5 Other clinical applications 158
TABLE 110 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 111 NORTH AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 112 EUROPE: QPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 113 ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 114 LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
7.2.2 RESEARCH APPLICATIONS 160
7.2.2.1 Growing genome-based research activity to boost market growth 160
TABLE 115 QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 161
TABLE 116 NORTH AMERICA: QPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 117 EUROPE: QPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 118 ASIA PACIFIC: QPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162
TABLE 119 LATIN AMERICA: QPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
7.2.3 FORENSIC APPLICATIONS 163
7.2.3.1 Growing crime rates and increasing application of genomic analysis in criminology & forensics to fuel growth 163
TABLE 120 QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 164
TABLE 121 NORTH AMERICA: QPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 122 EUROPE: QPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 123 ASIA PACIFIC: QPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 124 LATIN AMERICA: QPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 166
7.2.4 ENVIRONMENTAL APPLICATIONS 166
7.2.4.1 Growing use of qPCR in environmental microbiology to drive market 166
TABLE 125 QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 167
TABLE 126 NORTH AMERICA: QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 127 EUROPE: QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 128 ASIA PACIFIC: QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 129 LATIN AMERICA: QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 169
7.2.5 OTHER APPLICATIONS 169
TABLE 130 OTHER QPCR APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 169
TABLE 131 NORTH AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 132 EUROPE: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 170
TABLE 133 ASIA PACIFIC: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 134 LATIN AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
7.3 DPCR APPLICATIONS 172
TABLE 135 DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 172
7.3.1 CLINICAL APPLICATIONS 172
TABLE 136 DPCR CLINICAL APPLICATIONS MARKET, BY TYPE 2021–2028 (USD MILLION) 173
TABLE 137 DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 173
TABLE 138 NORTH AMERICA: DPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 139 EUROPE: DPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 140 ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
TABLE 141 LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 175
7.3.1.1 Infectious disease testing 176
7.3.1.1.1 Accuracy and precision of dPCR to boost demand in infectious disease testing 176
TABLE 142 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2021–2028 (USD MILLION) 176
TABLE 143 NORTH AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 144 EUROPE: DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 145 ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 146 LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 178
7.3.1.2 Oncology testing 179
7.3.1.2.1 dPCR to play vital role in oncology testing and clinical studies 179
TABLE 147 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2021–2028 (USD MILLION) 179
TABLE 148 NORTH AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 149 EUROPE: DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 180
TABLE 150 ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 151 LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 181
7.3.1.3 Blood screening 182
7.3.1.3.1 Multiple advantages of dPCR over traditional techniques to drive blood screening market 182
TABLE 152 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2021–2028 (USD MILLION) 182
TABLE 153 NORTH AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 154 EUROPE: DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 155 ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 156 LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 184
7.3.1.4 Transplant diagnostics 185
7.3.1.4.1 Shortage of dPCR products for transplant diagnostics to limit market growth 185
TABLE 157 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2021–2028 (USD MILLION) 185
TABLE 158 NORTH AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 159 EUROPE: DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 160 ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 161 LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION) 187
7.3.1.5 Other clinical applications 188
TABLE 162 DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 188
TABLE 163 NORTH AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 188
TABLE 164 EUROPE: DPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 165 ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 166 LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 190
7.3.2 RESEARCH APPLICATIONS 190
7.3.2.1 Wide usage of dPCR in genetic research to drive market 190
TABLE 167 DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 191
TABLE 168 NORTH AMERICA: DPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 169 EUROPE: DPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 170 ASIA PACIFIC: DPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 171 LATIN AMERICA: DPCR RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 193
7.3.3 FORENSIC APPLICATIONS 193
7.3.3.1 Need to reduce time & cost of forensic processes to drive market growth 193
TABLE 172 DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 194
TABLE 173 NORTH AMERICA: DPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 174 EUROPE: DPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 175 ASIA PACIFIC: DPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 176 LATIN AMERICA: DPCR FORENSIC APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 196
7.3.4 ENVIRONMENTAL APPLICATIONS 196
7.3.4.1 Increasing adoption of dPCR for wastewater surveillance to propel growth 196
TABLE 177 DPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 197
TABLE 178 NORTH AMERICA: DPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 197
TABLE 179 EUROPE: DPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 180 ASIA PACIFIC: DPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 181 LATIN AMERICA: DPCR ENVIRONMENTAL APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 199
7.3.5 OTHER APPLICATIONS 199
TABLE 182 OTHER DPCR APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 199
TABLE 183 NORTH AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 200
TABLE 184 EUROPE: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 200
TABLE 185 ASIA PACIFIC: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 186 LATIN AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201
8 DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET, BY END USER 202
8.1 INTRODUCTION 203
TABLE 187 QPCR END USER MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 203
8.2 QPCR END USERS 203
TABLE 188 QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 204
8.2.1 HOSPITALS AND DIAGNOSTIC LABORATORIES 204
8.2.1.1 Increased use of qPCR for disease diagnosis to drive segmental growth 204
TABLE 189 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 205
TABLE 190 NORTH AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 205
TABLE 191 EUROPE: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 192 ASIA PACIFIC: QPCR FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 206
TABLE 193 LATIN AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 207
8.2.2 ACADEMIC AND RESEARCH INSTITUTES 207
8.2.2.1 Propelling use of qPCR in genetic & molecular studies likely to drive segmental growth 207
TABLE 194 QPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 208
TABLE 195 NORTH AMERICA: QPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 196 EUROPE: QPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 197 ASIA PACIFIC: QPCR FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 198 LATIN AMERICA: QPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 210
8.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 210
8.2.3.1 Adoption of digital PCR in drug discovery and development to upsurge market growth 210
TABLE 199 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 211
TABLE 200 NORTH AMERICA: QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 201 EUROPE: QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 202 ASIA PACIFIC: QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 203 LATIN AMERICA: QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 213
8.2.4 CROS AND CDMOS 213
8.2.4.1 Increased outsourcing of drug development services to drive market 213
TABLE 204 QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2021–2028 (USD MILLION) 214
TABLE 205 NORTH AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 206 EUROPE: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 215
TABLE 207 ASIA PACIFIC: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 215
TABLE 208 LATIN AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 216
8.2.5 FORENSIC LABORATORIES 216
8.2.5.1 Acceptance of qPCR-based techniques for forensic studies anticipated to increase demand 216
TABLE 209 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 217
TABLE 210 NORTH AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 211 EUROPE: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 212 ASIA PACIFIC: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 218
TABLE 213 LATIN AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 219
8.2.6 OTHER END USERS 219
TABLE 214 QPCR MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 219
TABLE 215 NORTH AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 216 EUROPE: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 217 ASIA PACIFIC: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 221
TABLE 218 LATIN AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 221
8.3 DPCR END USERS 222
TABLE 219 DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 222
8.3.1 HOSPITALS AND DIAGNOSTIC LABORATORIES 222
8.3.1.1 Increased use of digital PCR for genomic testing to drive segmental growth 222
TABLE 220 DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 223
TABLE 221 NORTH AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 223
TABLE 222 EUROPE: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, 2021–2028 (USD MILLION) 224
TABLE 223 ASIA PACIFIC: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 224
TABLE 224 LATIN AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 225
8.3.2 ACADEMIC AND RESEARCH INSTITUTES 225
8.3.2.1 Rise in research collaborations and increased funding likely to propel segmental growth 225
TABLE 225 DPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 226
TABLE 226 NORTH AMERICA: DPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 226
TABLE 227 EUROPE: DPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, 2021–2028 (USD MILLION) 227
TABLE 228 ASIA PACIFIC: DPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 227
TABLE 229 LATIN AMERICA: DPCR MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 228
8.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 228
8.3.3.1 Increased investment in research and development to drive demand for dPCR 228
TABLE 230 DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 229
TABLE 231 NORTH AMERICA: DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 229
TABLE 232 EUROPE: DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 230
TABLE 233 ASIA PACIFIC: DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 230
TABLE 234 LATIN AMERICA: DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 231
8.3.4 CROS AND CDMOS 231
8.3.4.1 Rise in clinical trials to drive market 231
TABLE 235 DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2021–2028 (USD MILLION) 232
TABLE 236 NORTH AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 232
TABLE 237 EUROPE: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 233
TABLE 238 ASIA PACIFIC: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 233
TABLE 239 LATIN AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021–2028 (USD MILLION) 234
8.3.5 FORENSIC LABORATORIES 234
8.3.5.1 Automation in forensic lab workflows likely to drive demand for dPCR 234
TABLE 240 DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 235
TABLE 241 NORTH AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 235
TABLE 242 EUROPE: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 236
TABLE 243 ASIA PACIFIC: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 236
TABLE 244 LATIN AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 237
8.3.6 OTHER END USERS 237
TABLE 245 DPCR MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 237
TABLE 246 NORTH AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 238
TABLE 247 EUROPE: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 238
TABLE 248 ASIA PACIFIC: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 239
TABLE 249 LATIN AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 239
9 DIGITAL PCR (DPCR) & REAL-TIME PCR (QPCR) MARKET, BY REGION 240
9.1 INTRODUCTION 241
TABLE 250 DPCR & QPCR MARKET, BY REGION, 2021–2028 (USD MILLION) 241
9.2 NORTH AMERICA 242
FIGURE 25 NORTH AMERICA: DPCR & QPCR MARKET SNAPSHOT 243
TABLE 251 NORTH AMERICA: DPCR & QPCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 244
TABLE 252 NORTH AMERICA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 244
TABLE 253 NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 245
TABLE 254 NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 245
TABLE 255 NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 256 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 246
TABLE 257 NORTH AMERICA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 258 NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 247
TABLE 259 NORTH AMERICA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 260 NORTH AMERICA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 248
TABLE 261 NORTH AMERICA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 249
9.2.1 US 249
9.2.1.1 High incidence of chronic and genetic diseases to drive market 249
TABLE 262 US: DPCR & QPCR APPLICATIONS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 250
TABLE 263 US: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 250
TABLE 264 US: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 251
TABLE 265 US: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 266 US: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 252
TABLE 267 US: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 268 US: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 253
TABLE 269 US: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 270 US: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 254
TABLE 271 US: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 254
9.2.2 CANADA 255
9.2.2.1 Government initiatives in support of genomics research to drive market in Canada 255
TABLE 272 CANADA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 255
TABLE 273 CANADA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 255
TABLE 274 CANADA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 256
TABLE 275 CANADA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 276 CANADA: QPCR APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 277 CANADA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 278 CANADA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 258
TABLE 279 CANADA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 258
TABLE 280 CANADA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 259
TABLE 281 CANADA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 259
9.2.3 NORTH AMERICA: RECESSION IMPACT 260
9.3 EUROPE 260
TABLE 282 EUROPE: DPCR & QPCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 261
TABLE 283 EUROPE: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 261
TABLE 284 EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 262
TABLE 285 EUROPE: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 262
TABLE 286 EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 263
TABLE 287 EUROPE: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 263
TABLE 288 EUROPE: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 289 EUROPE: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 264
TABLE 290 EUROPE: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 265
TABLE 291 EUROPE: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 265
TABLE 292 EUROPE: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 266
9.3.1 GERMANY 266
9.3.1.1 Germany to dominate European dPCR & qPCR market 266
TABLE 293 GERMANY: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 267
TABLE 294 GERMANY: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 267
TABLE 295 GERMANY: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 268
TABLE 296 GERMANY: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268
TABLE 297 GERMANY: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 269
TABLE 298 GERMANY: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 269
TABLE 299 GERMANY: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 270
TABLE 300 GERMANY: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 270
TABLE 301 GERMANY: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 271
TABLE 302 GERMANY: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 271
9.3.2 UK 272
9.3.2.1 Growing focus on genomics research to support market 272
TABLE 303 UK: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 272
TABLE 304 UK: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 272
TABLE 305 UK: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 273
TABLE 306 UK: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 307 UK: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 274
TABLE 308 UK: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 309 UK: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 275
TABLE 310 UK: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 275
TABLE 311 UK: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 276
TABLE 312 UK: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 276
9.3.3 FRANCE 277
9.3.3.1 Growing initiatives for genomic medicine to support market 277
TABLE 313 FRANCE: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 277
TABLE 314 FRANCE: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 278
TABLE 315 FRANCE: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 278
TABLE 316 FRANCE: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 317 FRANCE: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 279
TABLE 318 FRANCE: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 280
TABLE 319 FRANCE: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 280
TABLE 320 FRANCE: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 321 FRANCE: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 281
TABLE 322 FRANCE: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 282
9.3.4 SPAIN 282
9.3.4.1 Increasing adoption of advanced diagnostic technologies to drive growth 282
TABLE 323 SPAIN: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 283
TABLE 324 SPAIN: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 283
TABLE 325 SPAIN: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 284
TABLE 326 SPAIN: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 327 SPAIN: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 285
TABLE 328 SPAIN: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 285
TABLE 329 SPAIN: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 286
TABLE 330 SPAIN: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 331 SPAIN: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 287
TABLE 332 SPAIN: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 287
9.3.5 ITALY 288
9.3.5.1 Rising incidence of target diseases to drive market in Italy 288
TABLE 333 ITALY: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 288
TABLE 334 ITALY: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 288
TABLE 335 ITALY: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 289
TABLE 336 ITALY: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 337 ITALY: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 290
TABLE 338 ITALY: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 290
TABLE 339 ITALY: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 291
TABLE 340 ITALY: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 341 ITALY: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 292
TABLE 342 ITALY: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 292
9.3.6 REST OF EUROPE 293
TABLE 343 REST OF EUROPE: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 293
TABLE 344 REST OF EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 293
TABLE 345 REST OF EUROPE: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 294
TABLE 346 REST OF EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 347 REST OF EUROPE: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 295
TABLE 348 REST OF EUROPE: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 295
TABLE 349 REST OF EUROPE: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 296
TABLE 350 REST OF EUROPE: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 351 REST OF EUROPE: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 297
TABLE 352 REST OF EUROPE: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 297
9.3.7 EUROPE: RECESSION IMPACT 298
9.4 ASIA PACIFIC 298
FIGURE 26 ASIA PACIFIC: DPCR & QPCR MARKET SNAPSHOT 299
TABLE 353 ASIA PACIFIC: DPCR & QPCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 300
TABLE 354 ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 300
TABLE 355 ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 301
TABLE 356 ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 301
TABLE 357 ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 358 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 302
TABLE 359 ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 360 ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 303
TABLE 361 ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 304
TABLE 362 ASIA PACIFIC: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 304
TABLE 363 ASIA PACIFIC: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 305
9.4.1 JAPAN 305
9.4.1.1 Strong research and healthcare infrastructure to support market growth in Japan 305
TABLE 364 JAPAN: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 306
TABLE 365 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 306
TABLE 366 JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 307
TABLE 367 JAPAN: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 368 JAPAN: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 308
TABLE 369 JAPAN: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 308
TABLE 370 JAPAN: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 309
TABLE 371 JAPAN: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 372 JAPAN: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 310
TABLE 373 JAPAN: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 310
9.4.2 CHINA 311
9.4.2.1 Healthcare infrastructure modernization to fuel market growth in China 311
TABLE 374 CHINA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 311
TABLE 375 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 312
TABLE 376 CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 312
TABLE 377 CHINA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 313
TABLE 378 CHINA: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 313
TABLE 379 CHINA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 380 CHINA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 314
TABLE 381 CHINA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 315
TABLE 382 CHINA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 315
TABLE 383 CHINA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 316
9.4.3 AUSTRALIA 316
9.4.3.1 Public awareness of applications of advanced medical diagnostic techniques to drive market in Australia 316
TABLE 384 AUSTRALIA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 317
TABLE 385 AUSTRALIA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 317
TABLE 386 AUSTRALIA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 318
TABLE 387 AUSTRALIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 388 AUSTRALIA: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 319
TABLE 389 AUSTRALIA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 390 AUSTRALIA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 320
TABLE 391 AUSTRALIA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 392 AUSTRALIA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 321
TABLE 393 AUSTRALIA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 321
9.4.4 INDIA 322
9.4.4.1 Large target patient population to support market growth in India 322
TABLE 394 INDIA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 322
TABLE 395 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 323
TABLE 396 INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 323
TABLE 397 INDIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 398 INDIA: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 324
TABLE 399 INDIA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 400 INDIA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 325
TABLE 401 INDIA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 326
TABLE 402 INDIA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 326
TABLE 403 INDIA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 327
9.4.5 REST OF ASIA PACIFIC 327
TABLE 404 REST OF ASIA PACIFIC: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 328
TABLE 405 REST OF ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 328
TABLE 406 REST OF ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 329
TABLE 407 REST OF ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 408 REST OF ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 330
TABLE 409 REST OF ASIA PACIFIC: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 330
TABLE 410 REST OF ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 331
TABLE 411 REST OF ASIA PACIFIC: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 331
TABLE 412 REST OF ASIA PACIFIC: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 332
TABLE 413 REST OF ASIA PACIFIC: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 332
9.4.6 ASIA PACIFIC: RECESSION IMPACT 333
9.5 LATIN AMERICA 333
TABLE 414 LATIN AMERICA: DPCR & QPCR MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 333
TABLE 415 LATIN AMERICA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 334
TABLE 416 LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 334
TABLE 417 LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 335
TABLE 418 LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 419 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 336
TABLE 420 LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336
TABLE 421 LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 337
TABLE 422 LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 337
TABLE 423 LATIN AMERICA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 338
TABLE 424 LATIN AMERICA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 338
9.5.1 BRAZIL 339
9.5.1.1 Increase in research activities and low trade barriers to drive market 339
TABLE 425 BRAZIL: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 339
TABLE 426 BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 340
TABLE 427 BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 340
TABLE 428 BRAZIL: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 341
TABLE 429 BRAZIL: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 341
TABLE 430 BRAZIL: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 342
TABLE 431 BRAZIL: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 342
TABLE 432 BRAZIL: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 343
TABLE 433 BRAZIL: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 343
TABLE 434 BRAZIL: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 344
9.5.2 MEXICO 344
9.5.2.1 Favorable trade agreements to improve access to dPCR and qPCR instruments in Mexico 344
TABLE 435 MEXICO: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 345
TABLE 436 MEXICO: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 345
TABLE 437 MEXICO: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 346
TABLE 438 MEXICO: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 346
TABLE 439 MEXICO: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 347
TABLE 440 MEXICO: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 347
TABLE 441 MEXICO: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 348
TABLE 442 MEXICO: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 348
TABLE 443 MEXICO: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 349
TABLE 444 MEXICO: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 349
9.5.3 REST OF LATIN AMERICA 350
TABLE 445 REST OF LATIN AMERICA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 350
TABLE 446 REST OF LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 350
TABLE 447 REST OF LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 351
TABLE 448 REST OF LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 351
TABLE 449 REST OF LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 352
TABLE 450 REST OF LATIN AMERICA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 352
TABLE 451 REST OF LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 353
TABLE 452 REST OF LATIN AMERICA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 353
TABLE 453 REST OF LATIN AMERICA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 354
TABLE 454 REST OF LATIN AMERICA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 354
9.5.4 LATIN AMERICA: RECESSION IMPACT 355
9.6 MIDDLE EAST & AFRICA 355
9.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH 355
TABLE 455 MIDDLE EAST & AFRICA: DPCR & QPCR MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 356
TABLE 456 MIDDLE EAST & AFRICA: QPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 356
TABLE 457 MIDDLE EAST & AFRICA: DPCR MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 357
TABLE 458 MIDDLE EAST & AFRICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 357
TABLE 459 MIDDLE EAST & AFRICA: QPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 358
TABLE 460 MIDDLE EAST & AFRICA: QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 358
TABLE 461 MIDDLE EAST & AFRICA: DPCR MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 359
TABLE 462 MIDDLE EAST & AFRICA: DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 359
TABLE 463 MIDDLE EAST & AFRICA: QPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 360
TABLE 464 MIDDLE EAST & AFRICA: DPCR MARKET, BY END USER, 2021–2028 (USD MILLION) 360
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 361
10 COMPETITIVE LANDSCAPE 362
10.1 INTRODUCTION 362
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 363
FIGURE 27 DPCR & QPCR MARKET: STRATEGIES ADOPTED 363
10.3 REVENUE SHARE ANALYSIS 364
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS (2020–2022) 364
10.4 MARKET SHARE ANALYSIS 365
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 365
TABLE 465 DPCR & QPCR MARKET: DEGREE OF COMPETITION 365
10.5 COMPANY EVALUATION QUADRANT 367
10.5.1 STARS 367
10.5.2 EMERGING LEADERS 367
10.5.3 PERVASIVE PLAYERS 367
10.5.4 PARTICIPANTS 368
FIGURE 30 DPCR & QPCR MARKET: COMPANY EVALUATION MATRIX, 2022 368
10.6 COMPETITIVE BENCHMARKING OF TOP 30 PLAYERS 369
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (30 COMPANIES) 369
TABLE 466 DPCR & QPCR MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 369
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (30 COMPANIES) 370
TABLE 467 DPCR & QPCR MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 370
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 371
10.7.1 PROGRESSIVE COMPANIES 371
10.7.2 STARTING BLOCKS 371
10.7.3 RESPONSIVE COMPANIES 371
10.7.4 DYNAMIC COMPANIES 371
FIGURE 31 DPCR & QPCR MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 372
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 373
TABLE 468 DPCR & QPCR MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 373
TABLE 469 DPCR & QPCR MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 374
10.9 COMPETITIVE SCENARIO AND TRENDS 374
10.9.1 PRODUCT LAUNCHES 374
TABLE 470 DPCR & QPCR MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO FEBRUARY 2023 374
10.9.2 DEALS 375
TABLE 471 DPCR & QPCR MARKET: DEALS, JANUARY 2020 TO FEBRUARY 2023 375
10.9.3 OTHER DEVELOPMENTS 376
TABLE 472 DPCR & QPCR MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO FEBRUARY 2023 376
11 COMPANY PROFILES 377
11.1 KEY PLAYERS 377
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 DANAHER CORPORATION 377
TABLE 473 DANAHER CORPORATION: COMPANY OVERVIEW 377
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 378
11.1.2 F. HOFFMANN-LA ROCHE LTD. 382
TABLE 474 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 382
FIGURE 33 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022) 383
11.1.3 THERMO FISHER SCIENTIFIC INC. 388
TABLE 475 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 388
FIGURE 34 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 389
11.1.4 QIAGEN N.V. 398
TABLE 476 QIAGEN N.V.: COMPANY OVERVIEW 398
FIGURE 35 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 399
11.1.5 BIO-RAD LABORATORIES, INC. 407
TABLE 477 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 407
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 408
11.1.6 AGILENT TECHNOLOGIES, INC. 412
TABLE 478 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 412
FIGURE 37 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 413
11.1.7 TAKARA BIO INC. 416
TABLE 479 TAKARA BIO INC.: COMPANY OVERVIEW 416
FIGURE 38 TAKARA BIO INC.: COMPANY SNAPSHOT (2022) 417
11.1.8 BECTON, DICKINSON AND COMPANY 420
TABLE 480 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 420
FIGURE 39 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 421
11.1.9 ABBOTT LABORATORIES 424
TABLE 481 ABBOTT LABORATORIES: COMPANY OVERVIEW 424
FIGURE 40 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 425
11.1.10 PROMEGA CORPORATION 427
TABLE 482 PROMEGA CORPORATION: COMPANY OVERVIEW 427
11.1.11 MERCK KGAA 429
TABLE 483 MERCK KGAA: BUSINESS OVERVIEW 429
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2021) 430
11.1.12 ENDRESS+HAUSER 435
TABLE 484 ENDRESS+HAUSER: COMPANY OVERVIEW 435
FIGURE 42 ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2021) 436
11.1.13 BIOMÉRIEUX 439
TABLE 485 BIOMÉRIEUX: COMPANY OVERVIEW 439
FIGURE 43 BIOMÉRIEUX: COMPANY SNAPSHOT (2022) 440
11.1.14 MERIDIAN BIOSCIENCE 442
TABLE 486 MERIDIAN BIOSCIENCE: COMPANY OVERVIEW 442
11.1.15 EPPENDORF AG 446
TABLE 487 EPPENDORF AG: COMPANY OVERVIEW 446
FIGURE 44 EPPENDORF AG: COMPANY SNAPSHOT (2022) 447
11.1.16 QUIDEL CORPORATION 448
TABLE 488 QUIDEL CORPORATION: COMPANY OVERVIEW 448
FIGURE 45 QUIDEL CORPORATION: COMPANY SNAPSHOT (2022) 449
11.1.17 STANDARD BIOTOOLS (FORMERLY FLUIDIGM) 451
TABLE 489 STANDARD BIOTOOLS: COMPANY OVERVIEW 451
FIGURE 46 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021) 452
11.1.18 ENZO BIOCHEM, INC. 455
TABLE 490 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 455
FIGURE 47 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2022) 456
11.1.19 STILLA TECHNOLOGIES 459
TABLE 491 STILLA TECHNOLOGIES: COMPANY OVERVIEW 459
11.1.20 JN MEDSYS PTE. LTD. 462
TABLE 492 JN MEDSYS PTE. LTD.: COMPANY OVERVIEW 462
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 464
11.2.1 BIONEER CORPORATION 464
TABLE 493 BIONEER CORPORATION: COMPANY OVERVIEW 464
11.2.2 ELITECH GROUP 465
TABLE 494 ELITECH GROUP: COMPANY OVERVIEW 465
11.2.3 QUANTA BIOSCIENCES 467
TABLE 495 QUANTA BIOSCIENCES: COMPANY OVERVIEW 467
11.2.4 SACACE BIOTECHNOLOGIES S.R.L. 468
TABLE 496 SACACE BIOTECHNOLOGIES S.R.L.: COMPANY OVERVIEW 468
11.2.5 BIO MOLECULAR SYSTEMS 470
TABLE 497 BIO MOLECULAR SYSTEMS: COMPANY OVERVIEW 470
11.2.6 BIOMEME, INC. 471
TABLE 498 BIOMEME, INC.: COMPANY OVERVIEW 471
11.2.7 KYRATEC 472
TABLE 499 KYRATEC: COMPANY OVERVIEW 472
11.2.8 LGC BIOSEARCH TECHNOLOGIES 473
TABLE 500 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW 473
11.2.9 ANTYLIA SCIENTIFIC 474
TABLE 501 ANTYLIA SCIENTIFIC: COMPANY OVERVIEW 474
11.2.10 GENOME DIAGNOSTICS PVT. LTD. 476
TABLE 502 GENOME DIAGNOSTICS PVT. LTD.: COMPANY OVERVIEW 476
12 APPENDIX 479
12.1 DISCUSSION GUIDE 479
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 484
12.3 CUSTOMIZATION OPTIONS 486
12.4 RELATED REPORTS 487
12.5 AUTHOR DETAILS 488